CNS Pharmaceuticals Cash Flow Statement 2018-2024 | CNSP

Fifteen years of historical annual cash flow statements for CNS Pharmaceuticals (CNSP).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$-18.85$-15.27$-14.50$-9.46$-3.88$-7.39
$0.00$0.01$0.01$0.01$0.02$0.02
$1.01$1.54$1.72$1.30$0.73$6.57
$1.01$1.55$1.74$1.31$0.75$6.59
$0$0$0$0$0$0
$0$0$0$0$0$0
$1.32$2.30$1.04$0.66$0.15$0.07
$2.38$0.86$-1.52$-0.32$-0.62$0.02
$3.70$3.16$-0.78$0.83$-0.43$0.08
$-14.14$-10.56$-13.54$-7.32$-3.55$-0.72
$0.00$0.00$-0.01$-0.02$-0.02$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$0.00$0.00$-0.01$-0.02$-0.02$0
$0$0$0$0$0$0
$-0.44$-0.43$-0.48$-0.04$-0.04$0.30
$-0.44$-0.43$-0.48$-0.04$-0.04$0.30
$5.28$16.04$4.99$14.22$10.29$0.98
$5.28$16.04$4.99$14.22$10.29$0.98
$0$0$0$0$0$0
$-0.20$0$0$-0.05$0$-0.12
$4.64$15.61$4.51$14.13$10.26$1.16
$-9.51$5.05$-9.04$6.80$6.69$0.44
$1.01$1.20$1.72$1.29$0.63$0.11
$0$0$0$0$0$0